DESCRIPTION OF THE SHARE BUYBACK PROGRAM & RESUMPTION OF THE LIQUIDITY CONTRACT

Nachrichtenquelle: globenewswire
10.08.2020, 17:45  |  135   |   |   

DESCRIPTION OF THE SHARE BUYBACK PROGRAM
RESUMPTION OF THE LIQUIDITY CONTRACT

Listing place: Euronext Paris
Code ISIN / Mnemo: FR0013233012 / IVA
Website: www.inventivapharma.com

Paris, August 10, 2020

Pursuant to the authorization granted by the shareholders at the Combined General Meeting of May 28, 2020 and the Board of Directors' meeting held on June 22, 2020, Inventiva:

  • Confirms the terms and conditions of the share buyback program; and
  • Announces the resumption of the liquidity contract related to Inventiva shares and the end of the stabilization period


2020-2021 SHARE BUYBACK PROGRAM

As required under articles 221-1 et seq. And 241-1 et seq. of the General Regulations of the French Financial Markets Authority (Autorité des Marchés Financiers - AMF), this document sets out the objectives and terms and conditions of the share buyback program approved by Inventiva's shareholders and allowing for the subsequent renewal and resumption of the liquidity contract.

 1.    Date of the General Meeting at which the 2020-2021 share buyback program was authorized by shareholders

On May 28, 2020, the Combined General Meeting authorized, in its twelfth resolution, the Board of Directors to intervene on Inventiva's shares, the main characteristics of which are described below.

 2.    Allocation of treasury shares per objective of the share buyback program as of July 31, 2020
      

The 14,361 treasury shares held as of July 31, 2020, are allocated for the purpose of ensuring the liquidity or animating the market for Inventiva's shares through an investment service provider acting independently under a liquidity contract that complies with a code of ethics approved by the AMF.

  1. Objectives of the share buyback program
     
    1. setting-up and honoring obligations under stock option programs or other allocations of shares to the Company's employees and executive officers and, in particular, to allocate shares to the Company's employees and executive officers in the context of
       
Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

DESCRIPTION OF THE SHARE BUYBACK PROGRAM & RESUMPTION OF THE LIQUIDITY CONTRACT DESCRIPTION OF THE SHARE BUYBACK PROGRAMRESUMPTION OF THE LIQUIDITY CONTRACT Listing place: Euronext ParisCode ISIN / Mnemo: FR0013233012 / IVAWebsite: www.inventivapharma.com Paris, August 10, 2020 Pursuant to the authorization …

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel

Diskussionen zu den Werten

ZeitTitel
12.10.20